Home › NDC Lookup › Drug shortages › Quinapril Hydrochloride Tablet

Quinapril Hydrochloride Tablet shortage

Quinapril Hydrochloride Tablet is currently listed in shortage by the FDA. The FDA lists 16 affected products. The reported reason: Requirements related to complying with good manufacturing practices; Discontinuation of the manufacture of the drug; Shortage of an active ingredient. This page was last refreshed from FDA data on Oct 2, 2026.

Current ⚠ Supply risk: Medium Cardiovascular 16 products 4 manufacturers 1,352 days · 3.7 yr First posted Jan 19, 2023 Updated Sep 15, 2026
Here’s the bottom line

Quinapril hydrochloride tablets are on the FDA shortage list, with most reporting manufacturers either discontinuing the product or facing long-term backlogs lasting over a year. The same medicine is still listed by other manufacturers — including Cipla USA, BluePoint Laboratories, and Proficient Rx — that have not reported a shortage.

Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
16
Affected NDCs
4
Reporting manufacturers
1/4
Reporting mfrs supplying
4/4
Affected strengths supplied
75%
NDCs unavailable
1,352
Days in shortage
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 2, 2026 · yesterday

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Quinapril Hydrochloride Tablet. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
16 NDCs
Available 4 Unavailable 12
Affected strengths still supplied
Among manufacturers reporting this shortage
4/4 strengths
Sourceable 4
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
1/4 makers
With supply 1 No supply 3
✓ Other manufacturers not reporting a shortage
Still-marketed Quinapril Hydrochloride Tablet from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Proficient Rx LP Aurobindo Pharma Limited BluePoint Laboratories Cipla USA Inc.
See all other options & details →
Shortage timeline
  1. Sep 15, 2026
    Currently in shortage
    16 of 16 products affected.
  2. Sep 1, 2026
    FDA refreshed this shortage record
    4 products updated.
  3. Jun 29, 2026
    FDA refreshed this shortage record
    4 products updated.
  4. Jun 2, 2026
    FDA refreshed this shortage record
    4 products updated.
  5. Jan 19, 2023
    First reported to the FDA
    16 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Aurobindo Pharma USA 📞 866-850-2876 4 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) NDC 65862-0618-90 — Unavailable Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug
Current Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) NDC 65862-0618-90 — Unavailable Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug
Current Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) NDC 65862-0617-90 — Unavailable Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug
Current Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90) NDC 65862-0620-90 — Unavailable Discontinuation of the manufacture of the drug Discontinuation of the manufacture of the drug
Manufacturer: Chartwell Molecular Holdings LLC 📞 845-268-5000 x 510 or Chartwell Customer service at [email protected] 4 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60) NDC 62135-0484-60 — Available — —
Current Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90) NDC 62135-0487-90 — Available — —
Current Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90) NDC 62135-0485-90 — Available — —
Current Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90) NDC 62135-0486-90 — Available — —
Manufacturer: Lupin Pharmaceuticals, Inc. 📞 Lupin Pharmaceuticals, Inc. 4 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09) NDC 68180-0557-09 — Unavailable Estimated recovery: TBD Requirements related to complying with good manufacturing pr...
Current Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09) NDC 68180-0554-09 — Unavailable Estimated recovery: TBD Requirements related to complying with good manufacturing pr...
Current Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09) NDC 68180-0556-09 — Unavailable Estimated recovery: TBD Requirements related to complying with good manufacturing pr...
Current Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09) NDC 68180-0558-09 — Unavailable Estimated recovery: TBD Requirements related to complying with good manufacturing pr...
Manufacturer: Solco Healthcare US, LLC 📞 866-931-9829 4 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09) NDC 43547-0413-09 — Unavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time. Shortage of an active ingredient
Current Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09) NDC 43547-0411-09 — Unavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time. Shortage of an active ingredient
Current Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09) NDC 43547-0410-09 — Unavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time. Shortage of an active ingredient
Current Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09) NDC 43547-0412-09 — Unavailable Not available. Long-term backorder for all NDCs. No estimated release date at this time. Shortage of an active ingredient

These rows are manufacturer reports to the FDA for Quinapril Hydrochloride Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Quinapril Hydrochloride Tablet? options further down this page.

Why is Quinapril Hydrochloride Tablet in shortage?

There are actually a few separate problems happening at once with quinapril tablets, depending on the manufacturer. Lupin Pharmaceuticals has had to stop supplying all four strengths of their quinapril tablets — the 5 mg, 10 mg, 20 mg, and 40 mg — because of issues meeting FDA manufacturing standards (think of it as the factory needing to fix certain quality requirements before they can ship product again). They haven't given a timeline for when supply will return. Aurobindo Pharma and Pfizer (who made the brand-name Accupril) have permanently stopped making all strengths of their quinapril tablets altogether — that's a full discontinuation, not a temporary pause. Solco Healthcare is also out of all four strengths with no estimated return date, and they've reported a shortage of the active ingredient itself as the cause.

It's worth knowing that this FDA report covers only the manufacturers listed here. Chartwell Molecular Holdings, also included in this report, is currently showing all four strengths — 5 mg, 10 mg, 20 mg, and 40 mg — as available.

FDA reason code(s): Requirements related to complying with good manufacturing practices; Discontinuation of the manufacture of the drug; Shortage of an active ingredient

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Quinapril Hydrochloride Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Quinapril Hydrochloride Tablet?

Quinapril hydrochloride tablets are currently on the FDA drug-shortage list. Because this affects a blood pressure medicine, I want to walk you through it calmly so you know where things stand.

All four strengths are involved on this report — 5 mg, 10 mg, 20 mg, and 40 mg. The reassuring part is that every one of these strengths still has an available source from at least one manufacturer. None of your strengths is listed as completely without supply.

The reasons reported here include a shortage of an active ingredient, manufacturing quality requirements, and some manufacturers discontinuing their version of the tablet. Of the five companies on this record, one is still reporting available supply, while others show long-term backorders with no set release date. This situation has lasted more than a year, so your pharmacy may need a little extra time to locate stock.

Here is what I suggest, in order:

  1. Keep taking your quinapril as prescribed — do not stop, skip, or change your dose on your own.
  2. Ask your pharmacy to order your strength; they can check wholesalers and other manufacturers, including makers of the same medicine still on the market.
  3. If your exact strength can't be found, ask your prescriber or pharmacist about options, such as a different strength to make up your dose.

Manufacturer contact numbers are listed on this page for reference, though pharmacies usually handle those calls.

See “Where else can I get Quinapril Hydrochloride Tablet?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Quinapril guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Quinapril guide →

Where else can I get Quinapril Hydrochloride Tablet?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Quinapril Hydrochloride Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Quinapril QUINAPRIL HYDROCHLORIDE 10 mg/1 Tablet, Film Coated · Oral Proficient Rx LP 63187-0874-30
Quinapril Hydrochloride QUINAPRIL HYDROCHLORIDE 5 mg/1 Tablet, Film Coated Aurobindo Pharma Limited 65862-0617-17
Quinapril QUINAPRIL HYDROCHLORIDE 10 mg/1 Tablet, Film Coated · Oral Aurobindo Pharma Limited 65862-0618-30
Quinapril QUINAPRIL HYDROCHLORIDE 20 mg/1 Tablet, Film Coated · Oral Aurobindo Pharma Limited 65862-0619-19
Quinapril Hydrochloride QUINAPRIL HYDROCHLORIDE 40 mg/1 Tablet, Film Coated Aurobindo Pharma Limited 65862-0620-30
Quinapril QUINAPRIL HYDROCHLORIDE 20 mg/1 Tablet · Oral BluePoint Laboratories 68001-0187-05
Quinapril QUINAPRIL HYDROCHLORIDE 10 mg/1 Tablet · Oral BluePoint Laboratories 68001-0188-05
Quinapril QUINAPRIL HYDROCHLORIDE 5 mg/1 Tablet · Oral BluePoint Laboratories 68001-0189-05
Quinapril QUINAPRIL HYDROCHLORIDE 40 mg/1 Tablet · Oral BluePoint Laboratories 68001-0260-05
Quinapril QUINAPRIL HYDROCHLORIDE 5 mg/1 Tablet · Oral Cipla USA Inc. 69097-0839-05
Quinapril QUINAPRIL HYDROCHLORIDE 10 mg/1 Tablet · Oral Cipla USA Inc. 69097-0841-05
Quinapril QUINAPRIL HYDROCHLORIDE 20 mg/1 Tablet · Oral Cipla USA Inc. 69097-0842-05
Therapeutic equivalents & pricing 23 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Quinapril 5 mgNDC 43547-0410-09 Solco 90 tablets $0.075 AB FDA listed
Quinapril Hydrochloride 5 mgNDC 65862-0617-90 Aurobindo 90 tablets $0.075 — FDA listed
Quinapril 5 mgNDC 68001-0189-05 BluePoint 90 tablets $0.075 AB FDA listed
Quinapril 40 mgNDC 43547-0413-09 Solco 90 tablets $0.096 AB FDA listed
Quinapril Hydrochloride 40 mgNDC 65862-0620-90 Aurobindo 90 tablets $0.096 — FDA listed
Quinapril 40 mgNDC 68001-0260-05 BluePoint 90 tablets $0.096 AB FDA listed
Quinapril 10 mgNDC 43547-0411-09 Solco 90 tablets $0.097 AB FDA listed
Quinapril 10 mgNDC 65862-0618-90 Aurobindo 90 tablets $0.097 AB FDA listed
Quinapril 10 mgNDC 68001-0188-05 BluePoint 90 tablets $0.097 AB FDA listed
Quinapril 10 mgNDC 62135-0485-90 Chartwell 90 tablets — AB FDA listed
Quinapril 10 mgNDC 63187-0425-30 Proficient 30 tablets — — FDA listed
Quinapril 10 mgNDC 63187-0874-30 Proficient 30 tablets — AB FDA listed
Quinapril 10 mgNDC 63629-7934-01 Bryant 30 tablets — AB FDA listed
Quinapril 10 mgNDC 69097-0841-05 Cipla 90 tablets — — FDA listed
Quinapril 10 mgNDC 71205-0484-30 Proficient 30 tablets — AB FDA listed
Quinapril 10 mgNDC 71205-0635-30 Proficient 30 tablets — AB FDA listed
Quinapril 10 mgNDC 71335-1134-01 Bryant 30 tablets — AB FDA listed
Quinapril 10 mgNDC 71335-1707-01 Bryant 30 tablets — AB FDA listed
Quinapril 5 mgNDC 62135-0484-60 Chartwell 60 tablets — AB FDA listed
Quinapril 5 mgNDC 69097-0839-05 Cipla 90 tablets — — FDA listed
Quinapril 40 mgNDC 51655-0737-52 Northwind 30 tablets — AB FDA listed
Quinapril 40 mgNDC 62135-0487-90 Chartwell 90 tablets — AB FDA listed
Quinapril 40 mgNDC 69097-0843-05 Cipla 90 tablets — — FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Quinapril Hydrochloride Tablet — that fall in the same broad treatment class (antihypertensives, ace inhibitors) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 018772
GCN 27570
HICL code 007631
Ingredient (HICL) Quinapril Hcl
HIC1 code A
Therapeutic class — broad (HIC1) Cardiovascular System
HIC2 code A4
Therapeutic class — intermediate (HIC2) Antihypertensives
HIC3 code A4D
Therapeutic class — specific (HIC3) Antihypertensives, Ace Inhibitors
AHFS code 24:32.04.00
AHFS class Angiotensin-Converting Enzyme Inhibitors
FDB label name QUINAPRIL 10 MG TABLET
FDB brand name Quinapril Hcl
Legend status F — Federal legend — prescription drug or device
GPI-1436100040100310
GPI classQuinapril HCl
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other cardiovascular shortages

Quinapril Hydrochloride Tablet shortage FAQs

Is Quinapril Hydrochloride Tablet in shortage?
Yes — the FDA currently lists Quinapril Hydrochloride Tablet in shortage (status: “Current”, first reported Jan 19, 2023). 16 of 16 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Why is Quinapril Hydrochloride Tablet in shortage?
The manufacturer-reported reason on file with the FDA: Requirements related to complying with good manufacturing practices; Discontinuation of the manufacture of the drug; Shortage of an active ingredient.
Which products are affected?
Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) (NDC 65862-0618-90); Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90) (NDC 65862-0618-90); Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90) (NDC 65862-0617-90). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Quinapril Hydrochloride Tablet be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Quinapril Hydrochloride somewhere?
Other manufacturers (Proficient Rx LP, Aurobindo Pharma Limited, BluePoint Laboratories and others) still market it and have not reported a shortage. See “Where else can I get Quinapril Hydrochloride Tablet?” above — stock still varies by pharmacy.
What should I do if I take Quinapril Hydrochloride Tablet?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Quinapril Hydrochloride Tablet shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages